Skip to main content

Head & Neck

Protocols

Nasopharyngeal Carcinoma

Locally Advanced Disease

HNNLAPG

Induction Treatment of Locally Advanced Nasopharyngeal Cancer with CISplatin and Gemcitabine


HNNLAPRT

Treatment of Locally Advanced Nasopharyngeal Cancer with Concurrent CISplatin and Radiation


Advanced Disease

HNNAVCAP

Treatment Of Recurrent Or Metastatic Nasopharyngeal Cancer With Capecitabine


HNNAVFUFA

Treatment of Recurrent or Metastatic Nasopharyngeal Cancer with Fluorouracil and Leucovorin


HNNAVFUP

Treatment for Advanced Nasopharyngeal Cancer of the Head and Neck using Platinum and Fluorouracil


HNNAVGEM

Treatment of Loco-regionally Recurrent/Metastatic Nasopharyngeal Cancer Not Amenable for Local Curative Therapy with Gemcitabine


HNNAVP

Palliative Chemotherapy for Advanced Head and Neck Nasopharyngeal Carcinoma with Weekly CISplatin


HNNAVPC

Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma with CARBOplatin and PACLitaxel


HNNAVPE

Treatment of Recurrent and/or Metastatic Nasopharyngeal Cancer with Platinum and Etoposide


HNNAVPG

Treatment of Locoregionally Recurrent and/or Metastatic Nasopharyngeal Cancer with Platinum and Gemcitabine


Top

Squamous Cell Carcinoma

Locally Advanced Disease

HNLAALTPRT

Treatment of Locally Advanced (Alternate) Head and Neck Cancer Using CISplatin during Radiation Therapy


HNLACART (see HNLACARTW)


HNLACART3

Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck with Concurrent 3-Weekly CARBOplatin and Radiation


HNLACARTW

Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck with Concurrent Weekly CARBOplatin and Radiation


HNLAPRT

Combined Chemotherapy (CISplatin) and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of The Head and Neck


HNLACAFRT

Combined Chemotherapy (CARBOplatin and Fluorouracil) and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck


HNLACETRT

Combined Cetuximab and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck


HNLADCF

Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck with DOCEtaxel, CISplatin and Infusional Fluorouracil


Advanced Disease

HNAVCAP

Treatment Of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck With Capecitabine


HNAVDOC

Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck with DOCEtaxel


HNAVFUFA

Fluorouracil and Leucovorin for Recurrent Head and Neck Cancer (Squamous Cell Carcinoma)


HNAVFUP

Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck Cancer Using Fluorouracil and Platinum


HNAVM

Treatment of Head and Neck Cancer Using Methotrexate as Standard Therapy


HNAVNIV

Palliative Therapy for Unresectable, Platinum-refractory, Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck Using Nivolumab


HNAVNIV4

Palliative Therapy for Unresectable, Platinum-refractory, Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck Using 4-Weekly Nivolumab


HNAVP

Palliative Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma with Weekly CISplatin


HNAVPC

Treatment for Unresectable, Locoregionally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Using PACLitaxel and CISplatin or CARBOplatin


HNAVPCPMB

First-Line Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck with PACLitaxel, CARBOplatin and Pembrolizumab


HNAVPD

Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck with Platinum and DOCEtaxel


HNAVPE

Treatment of Recurrent and Metastatic Squamous Cell Cancer with Platinum and Etoposide


HNAVPFPMB

First-Line Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck Using Platinum, Fluorouracil and Pembrolizumab


HNAVPMBF

First-Line Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck with Pembrolizumab


HNAVPMBF6

First-Line Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck using 6-Weekly Pembrolizumab


HNAVPMBM

Maintenance Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck with Pembrolizumab


HNAVPMBM6

Maintenance Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck using 6-Weekly Pembrolizumab

Top

Other

HNOTDCABO

Therapy of Advanced Differentiated Thyroid Cancer using Cabozantinib


HNOTAVD

Palliative Therapy for Advanced Thyroid Cancers Using DOXOrubicin


HNOTDSEL

Therapy of Advanced RET Fusion-Positive Differentiated Thyroid Cancer using Selpercatinib


HNOTLEN

Therapy for Locally Recurrent or Metastatic, RAI-refractory Differentiated Thyroid Cancer Using Lenvatinib


HNOTMSEL

Treatment of Advanced RET-Mutant Medullary Thyroid Cancer using Selpercatinib


HNOTTSH

Radioiodine Imaging in Patients with Thyroid Cancer using Thyrotropin Alpha


HNOTVAN

Treatment for Locally Advanced or Metastatic Medullary Thyroid Cancer Using vanDETanib

Top

Salivary Tumours

HNSAVFAC

Palliative Therapy for Advanced Salivary Gland Cancers Using Cyclophosphamide, DOXOrubicin and Fluorouracil


HNSAVFUP

Treatment of Advanced Head and Neck Cancer Using CISplatin and Fluorouracil


HNSAVNP

Treatment of Advanced Salivary Gland Cancers With CISplatin and Vinorelbine


HNSAVPAC

Treatment of Advanced Salivary Gland Cancers With Platinum, DOXOrubicin and Cyclophosphamide

HNSAVTAM

Treatment of Recurrent/Metastatic Salivary Gland Cancers of the Head and Neck With Tamoxifen

Funding Algorithm

The funding algorithm provides information on what anti-cancer systemic therapy treatments are covered on the BC Cancer Benefit Drug List (formulary). It may not be a complete list of all treatment options that may be available and recommended by the treating physician.

Terms of use

The information contained in these documents is a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer's terms of use.

Tab Heading
SOURCE: Head & Neck ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2024 Provincial Health Services Authority